Reshaping Digestive Surgery
Location: France
Employees: 11-50
Total raised: $104.35M
Founded date: 2015
Investors 2
| Date | Name | Website |
| - | Sofinnova ... | sofinnovap... |
| 10.09.2025 | Asabys Par... | asabys.com... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 11.09.2025 | Series C | $11.69M | Sofinnova ... |
| 01.05.2025 | Series C | $39.54M | - |
| 08.02.2022 | - | $45.71M | - |
| 23.03.2018 | Series A | $7.42M | - |
Mentions in press and media 10
| Date | Title | Description |
| 11.09.2025 | SafeHeal Raises $10M Series C Extension Funding | SafeHeal, a Paris, France-based medical device company, raised $10M in extension of its €35M Series C funding. The round was led by Asabys Partners through its Sabadell Asabys II fund, which joined a syndicate that included Sofinnova Partne... |
| 10.09.2025 | Paris’ SafeHeal raises additional €10 million to transform colorectal surgery for cancer patients | French MedTech startup SafeHeal, a medical device innovator transforming colorectal surgery, today announced a €10 million extension of its oversubscribed €35 million Series C financing round. The extension is led by Asabys Partners through... |
| 14.08.2025 | SafeHeal® Receives European Marketing Approval Under MDR for Colovac® Anastomosis Protection Technology | Marketing approval allows imminent commercialization of the Colovac device in key EU markets NEW YORK, NY, UNITED STATES, August 14, 2025 /EINPresswire.com/ -- SafeHeal®, a leading innovator in the field of colorectal cancer surgery, today ... |
| 06.05.2025 | SafeHeal® Closes Oversubscribed €35 Million Series C Equity Financing | NEW YORK, NY, UNITED STATES, May 6, 2025 /EINPresswire.com/ -- Financing led by Solar Eclipse with new investors Gideon Strategic Partners and M&L Healthcare, part of M&L Group, and returning investors Sofinnova Partners and one of ... |
| 01.05.2025 | SafeHeal Closes €35M Series C Equity Financing | SafeHeal, a Paris, France- and Tampa, FL-based colorectal cancer surgery company, raised €35M in Series C equity funding. The round was led by Solar Eclipse with new investors Gideon Strategic Partners and M&L Healthcare, part of M&... |
| 11.07.2022 | SafeHeal Appoints Medical Device Industry Veteran Chris Richardson as Chief Executive Officer | PARIS, FRANCE and TAMPA, FL / ACCESSWIRE / July 11, 2022 / SafeHeal, a leading innovator in the field of digestive surgery and developer of the Colovac device, announced today the appointment of Chris Richardson as Chief Executive Officer (... |
| 08.02.2022 | SafeHeal raises €40M for ‘new standard of care’ in digestive surgery | Credit: SafeHeal |
| 31.01.2022 | Sofinnova Partners: SafeHeal Closes ?40 Million Financing Co-Led by Sofinnova Partners and Genesis MedTech To Finance Its Colovac Device Through a Pivotal Clinical Trial in the United States | DGAP-News: Sofinnova Partners / Key word(s): Miscellaneous Sofinnova Partners: SafeHeal Closes ?40 Million Financing Co-Led by Sofinnova Partners and Genesis MedTech To Finance Its Colovac Device Through a Pivotal Clinical Trial in the Unit... |
| 23.03.2018 | SafeHeal Raises €6M in Series A Financing | SafeHeal, a Paris, France-based early-stage medtech company specialized in digestive surgery and focused on the development of the Colovac device, closed a €6m Series A financing round. The round was led by Sofinnova Partners. The company w... |
| - | Paris-based devicemaker SafeHeal gets €40 million booster for transforming digestive surgery | French innovator in the field of digestive surgery and developer of the Colovac device, SafeHeal has raised €40 million funding. The round was co-led by European venture capital firm Sofinnova Partners and Singapore-based Genesis MedTech Gr... |